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Detection of biomolecules that were considered as important biological targets is a 
crucial tool in the field of clinical diagnosis and drug discovery. In general, most 
of the typical methods such as gel electrophoresis, immunoassay, antibody based 
assay have been showed relatively low specificity and sensitivity compared to 
required specifications for high level bio-analysis. These systems are laborious, 
time/cost-consuming, and not suitable for high throughput assay. Recently, 
alternative approaches have been developed based on nanomaterials such as gold 
nanoparticles, mesoporous silica nanoparticles and carbon based materials for 
noticeable improvement of the sensing performance. These nanomaterials have 
been applied in fluorescence, electrochemistry, mass spectrometry or SERS 
(Surface Enhanced Raman Scattering) based biosensors. These systems also 
enabled more rapid, cost and time-effective analysis, compared with conventional 
methods, thus they can provide a means in the field of target related basic research 
and further applications.  




for quantitative analysis of various biomarkers in clinical diagnosis and drug 
discovery. GO, a water-soluble version of graphene, has come into the spotlight in 
development of bioanalytical system due to its remarkable electronic, mechanical 
and thermal properties. Among these properties, the general strategy in this study 
relies on the fluorescence-quenching capability of GO for fluorescent molecules 
within short distance (~ 20 nm). By using fluorescent probes or substrates, this GO-
based platforms allow real-time measurement and quantitative analysis for various 
biomolecules such as nucleic acids and enzymes in short time. In this study, we 
developed 5 bioanalytical platforms which were classified into two categories 
according to each purpose: 1) nucleic acid detection platforms for analysis of 
double stranded DNA, single stranded DNA or RNA, single nucleotide 
polymorphism (SNP), 2) enzyme assay platforms for analysis of DNA exonuclease 
and protein kinase. Commonly, they could overcome the limitations of classical 
approaches and showed various applicability for further application. We believe 
that the present platforms will become an important assay tool in the field of 




keywords : bioanalysis, graphene oxide, fluorescence, high throughput assay, 
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1.1 Nanotechnology for Bio-Application  
Nanoscale materials recently have been developed and harnessed in diverse 
biological applications due to their large surface area, small size and unique 
properties.1 Significantly, the field of biological analysis has actively employed 
various kinds of nanomaterials such as metallic nanoparticles,2 quantum dots,3 
magnetic nanoparticles,4 silica5 or carbon based nanomaterials6, fitting for each 
purpose. These sensors were designed based on understanding at a molecular 
level how it works, resulting in noticeable improvement of the sensing 
performance compared to conventional systems.  
For example, various carbon materials have been applied in fluorescence,6a 
electochemistry,7 mass spectrometry8 or surface enhanced raman scattering 
(SERS)9 based biosensors, presenting improved sensitivity and specificity. These 
systems also enabled more rapid, cost and time-effective analysis, compared with 
conventional methods, thus they can provide a means in the field of target related 
basic research and further applications. Therefore, it is worth to develop 







1.2  Graphene Oxide 
In 2004, Chernogolovka discovered graphene planes detached by scotch tape and 
improved its high electric conductivity.10 The isolated atomic plane of graphite is 
a 2-dimensional nanomaterial with extraordinary electronic, thermal, and 
mechanical properties.11 Since then, graphene has stimulated intense interest and 
has been extensively studied theoretically and experimentally in various fields. 
Graphene oxide (GO) is a water dispersible version of graphene presenting 
oxygen-containing functional groups such as hydroxyl, carboxyl, and epoxy 
groups.12 On the basis of the unique properties of graphene and amphiphilicity, 
GO has been recently harnessed in diverse biological applications such as drug 
delivery,13 catalysis14 and biosensor15 in the last decade. In 2009, Guo-Nan Chen 
firstly demonstrated that GO can be used in a fluorometric assay for fast, sensitive, 
and selective detection of biomolecules and this platform is cost-effective 
compared to platform based on carbon nanotube.15 General strategy in this 
application relies on the strong binding of single stranded nucleic acid with GO 
through pi-pi stacking and/or hydrogen bonding interactions and the 
fluorescence-quenching capability of GO. Since then, many studies based on GO 
have been processed in the field of bio-analysis for further applications such as 
live cell imaging16 and enzymatic assay.17 Here, we have suggested improved 
strategies for analysis of biomolecules that were considered as important 




1.3 Description of Researches 
 
1.3.1 Direct, Sequence-Specific Detection of dsDNA Based on Peptide 
Nucleic Acid and Graphene Oxide without Requiring Denaturation18 
Direct, sequence-specific dsDNA detection system was developed without 
requiring any thermal denaturing step. Our strategy utilizes peptide nucleic acid 
(PNA) and graphene oxide (GO) as a probe and as a fluorescence quencher, 
respectively. Unlike other dsDNA sensors based on complementary DNA probes, 
PNA in combination with GO provided tighter turn-on signal control with very 
low background signal and high sensitivity and sequence selectivity even in the 
presence of serum proteins. 
 
 







1.3.2 Bovine Serum Albumin: A Simple Strategy for Practical 
Applications of PNA in Bioanalysis 
We employed bovine serum albumin (BSA) in PNA applications as an additive 
for preventing its adsorption on hydrophobic surfaces and increasing the ratio of 
soluble PNA in a solution. Moreover, the usage of BSA can be extended to 
blocking the adsorption of PNA/DNA duplex on graphene oxide (GO) surface, 
which is very effective for improving the performance of nucleic acid biosensing 
platform based on PNA and GO. 
 
 
Scheme 1.2  BSA blocking to (a) prevent the nonspecific adsorption of PNA 
on hydrophobic surface and (b) inhibit the adsorption of PNA/DNA duplex on 





1.3.3 A New Strategy for Nucleic Acid Detection with High Sequence 
Specificity Using Graphene Oxide and Peptide Nucleic Acid 
In this study, a robust strategy for extremely high sequence specific nucleic acid 
detection was suggested by using dye conjugated pep-tide nucleic acid and 
graphene oxide. By controlling the dissociation temperature of pre-hybridized 
PNA/target in the presence of GO, fluorescence intensity for mismatched target 
was selectively quenched and thus we can measure the signal for perfect matched 
target quantitatively.   
 
 
Scheme 1.3  A strategy for single mismatch discrimination in miRNA using 








1.3.4 A Simple DNA Exonuclease Activity Assay Based on Graphene 
Oxide19  
A new DNA exonuclease activity assay method was developed based on the 
preferential binding of single-stranded DNA (ssDNA) over double-stranded DNA 
(dsDNA) to graphene oxide (GO) (Scheme 1.1). By measuring the quenching and 
recovery of fluorescence of dye conjugated to double strand part, exonuclease 
activity can be assayed. This GO-based approach allows a simple and quantitative 
activity measurement in a short time at a low cost compared to conventional 
methods.  
 









1.3.5 Robust and Quantitative Platform for Multiplexed Protein 
Kinase Inhibitor Screening 
This new platform for protein kinase activity assay was established by using TiO2 
decorated graphene oxide, which is applicable in high throughput inhibitor 
screening. On the basis of strong affinity of TiO2 for phosphate group and 
fluorescence super-quenching ability of GO, phosphorylation of substrate by 
protein kinase was quantitatively detected in a short time. Utility of the present 
platform was proven by discovering the inhibitors through multiplexed inhibitor 
screening for two protein kinase using hundreds of bioactive compounds. 
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2. A Direct, Sequence-Specific Detection of dsDNA Based 
on Peptide Nucleic Acid and Graphene Oxide without 
Requiring Denaturation 
 
2.1  Introduction 
DNA detection is important in diagnosis and monitoring the fatal infections 
caused by viruses such as hepatitis virus, human immunodeficiency virus (HIV), 
ebola virus (EV) and severe acute respiratory syndrome (SARS) corona virus as 
well as diseases associated with genetic alterations.1-3 Conventional DNA 
detection methods, such as southern blot,4 fluorescence in situ hybridization 
(FISH),5 polymerase chain reaction (PCR)6 and DNA microarray7,8 are based on 
the sequence specific recognition of single stranded nucleic acid through Watson-
Crick base pairing. Recently, alternative approaches based on nanomaterials have 
been developed for simple and fast DNA detection.9-11 
In general, denaturing procedure is necessary to separate two DNA strands 
prior to sensing of the target DNA by hybridization with probe molecule or 
sequence because target DNA usually exists in duplex form with complementary 
strand. In such a case, spontaneous reannealing of original two DNA strands 
could disturb the hybridization of the target DNA with probe and lower the 




denaturation and/or rehybridization have been proposed. These direct detection 
methods utilized double-stranded DNA (dsDNA) binding probes such as zinc 
finger DNA binding proteins,12 pyrrole-imidazole polyamides (PAs)13,14 for 
binding at minor groove of dsDNA and triplex-forming oligonucleotides (TFOs)15 
for Hoogsteen hydrogen bonding at major groove of dsDNA. However, these 
approaches have drawbacks such as low chemical stability of protein as a probe 
and limitation in recognition length or sequence. Therefore, it is important to 
establish a robust, versatile and efficient sensing platform for direct dsDNA 
detection. 
Graphene is a 2D carbon material with remarkable electronic, thermal, and 
mechanical properties.16-18 Graphene oxide (GO), a water-soluble derivative of 
graphene, has been recently harnessed in diverse biological applications such as 
drug delivery, catalysis, enzyme activity assay and biosensor.10,19-26 General 
strategy in these applications relies on the strong binding of single stranded 
nucleic acid and/or hydrophobic molecules with GO through pi-pi stacking and/or 
hydrogen bonding interactions and the fluorescence-quenching capability of 
GO.27-30 
Here, we report a direct dsDNA detection method based on the end invasion 
of peptide nucleic acid (PNA) towards dsDNA and preferential binding of GO to 
single-stranded PNA (ssPNA) over DNA/PNA duplex. PNA is a DNA analogue 




complementary DNA or RNA with high sequence specificity in short time. The 
duplex of PNA with natural nucleic acid has high stability in various buffered 
conditions and at high temperature, basically due to the uncharged neutral 
backbone of PNA. Typically, DNA/PNA duplex shows at least 1°C higher 
melting temperature per base pair than DNA duplex.33 In addition to its widely 
known favorable properties as a biological probe, PNA could also interact with 
negatively charged GO stronger than negatively charged nucleic acids and 
construct stable PNA/GO complex, showing lower background signals due to less 
non-specific desorption of probe nucleic acid from GO.34-36 
The present strategy starts with preparation of a fluorescent dye conjugated 
PNA probe and a target dsDNA which consists of an upper strand as an actual 
target DNA for PNA probe recognition and a bottom strand complementary to 
target DNA. Upon incubation of dsDNA with PNA probe, the PNA binds at the 
end of upper strand because the hydrogen bonding at the terminal base pair of 
DNA duplex is weaker than internal one. Due to the superior binding affinity of 
PNA to complementary DNA, branch migration for strand replacement occurs 
gradually. Finally, the bottom DNA strand is dissociated from original DNA 
duplex and PNA/DNA duplex is formed.37-39 Upon addition of GO to this mixture, 
free PNA probe, not PNA/DNA duplex, preferentially binds onto GO through pi-
pi stacking interaction and hydrogen bonding formation, and subsequently, the 




GO. Therefore, only PNAs forming duplexes with target DNA emit the 
fluorescence signal, and thus, the initial concentration of the target dsDNA could 
be quantitatively analyzed (Scheme 2.1). 
 


















2.2  Result 
Before the demonstration of the present dsDNA sensor based on PNA and GO, 
the DNA strand replacement from dsDNA by PNA was first examined by 
resolving the PNA/DNA duplex and intact dsDNA using nondenaturing 
polyacrylamide gel electrophoresis (native - PAGE). Due to less negative charge 
of PNA/DNA duplex compared to DNA/DNA duplex, the band of the hetero 
duplex appeared at upper region, implying slower migration than DNA duplex in 
the gel. When the PNA probe was added to dsDNA, PNA was expected to first 
bind to the end site of dsDNA, followed by branch migration and complete 
hybridization between PNA and DNA along with separation of bottom strand 
DNA (Figure 2.1a). Next, we determined the optimal GO40 concentration for 
quenching the fluorescence of fluorescein amidite (FAM) labeled ssPNA probe (5’ 












Figure 2.1   Target strand invasion and GO adsorption of PNA strands. a) Gel 
electrophoresis was performed on a 15% native -PAGE. Lanes 1-4 show each 10 
pmol of ssPNA, dsDNA, ssDNA (bottom strand) and ssDNA (upper strand). 
Lanes 5-7 show 10 pmol of dsDNA incubated with 5, 10, 20 pmol of PNA. Lanes 
8-10 show 10 pmol of ssDNA (upper strand) incubated with 5, 10, 20 pmol of 
PNA. b) Fluorescence spectra of FAM labeled PNA in the presence of GO (0 μg 




We found that the fluorescence of FAM-PNA probe was quenched up to 
~98% in the presence of GO (0.5 μg), giving maximum quenching efficiency 




based fluorometric detection of dsDNA. Various concentrations of target dsDNA 
solutions ranging from 0 to 400 nM were mixed with FAM-PNA probe and then, 
GO solution was added. The fluorescence emission spectra of the mixed solutions 
of dsDNA, FAM-PNA and GO showed the dsDNA concentration dependent 
fluorescence enhancement with high sequence specificity showing no notable 
fluorescence intensity from a mixture containing scrambled dsDNA in place of 
target dsDNA (Figure 2.2a). This sensor showed a linear fluorescence increase 
between 0 and 2000 pM with the detection limit of 260 pM according to the 
equation, LOD = 3.3 (SD / S) (LOD: limit of detection, SD: standard deviation, 













Figure 2.2   Direct dsDNA detection in buffered solution. a) Fluorescence 
spectra of FAM-PNA probe in the presence of various concentrations of dsDNA 
target and scrambled dsDNA 400 nM in buffered solution with addition of GO. b) 
Fluorescence intensity enhancement (F/F0) with a wide concentration ranges of 
target dsDNA from 0 to 100 nM (F: fluorescence intensity of PNA probe 
hybridized with target, F0: fluorescence intensity of PNA probe without target).  
 
 
    As a control, we performed same experiment with FAM-DNA probe in place 
of FAM-PNA probe. FAM-DNA probe showed significant signal increase upon 
addition of scrambled DNA followed by addition of GO, which is estimated as 
~50% of the fluorescence intensity measured from the mixture of FAM-DNA 
probe, perfect matched target DNA and GO. The control data suggested that 
DNA probe is much less attractive for this type of direct, sequence-specific, 
quantitative detection of dsDNA due to high background fluorescence (Figure 
2.3).   
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Figure 2.3  Comparison between DNA probe and PNA probe in dsDNA 
detection. Fluorescence intensity enhancement (F/F0) of a) PNA probe and b) 
DNA probe in the presence of scrambled ssDNA, target dsDNA, target ssDNA (0, 
5, 10 pmol, respectively). c) Relative fluorescence intensity of FAM dye labeled 
DNA(10 pmol) in the presence of GO. For dsDNA detection using DNA probe, 
reaction mixture was prepared by 100 nM FAM labeled DNA probe incubated 
with the annealed target dsDNA in 1XPBS. After incubation at room temperature 
for 1hr, 3 μL of 500 μg/ml GO stock was added to mixture for adsorption of 
ssDNA on GO surface, which was 3-fold higher than PNA probe used system.  
 
 
   Furthermore, to investigate the applicability for direct sensing of dsDNA in 
serum containing biological samples, we repeated the dsDNA detection in 
buffered solutions containing 10% fetal bovine serum (FBS). Under the condition, 
















































range of target DNA (0 ~ 2000 pM) with a slightly higher detection limit of 400 
pM according to the equation, LOD = 3.3 (SD / S) (Figure 2.4).  
 
Figure 2.4 Direct dsDNA detection in serum containing colution a) Relative 
fluorescence spectra of FAM conjugated to PNA incubated with GO (0 μg, 0.5 μg 
and 2.5 μg, respectively) in a buffered solution containing 10 % FBS. b) 
Fluorescence spectra of PNA probe in presence of various concentration of 
dsDNA target and scrambled dsDNA 400nM in bufffered solution containing 10% 
FBS. c) Fluorescence intensity enhancement (F/F0) with wide concentration range 
of target in buffered solution containing 10% FBS.  
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   Next, we performed discrimination test between perfect matched target 
sequence and mismatched DNAs possessing one or three base pair (bp) 
mismatches. Precise recognition of few base mismatches in DNA sequences 
having very high sequence similarity is important because it provides information 
on genetic mutation, DNA damage and single-nucleotide polymorphism (SNP).41-
43 One and three bp mismatched DNAs were designed based on transversion 
mismatch at internal bases (A↔T). As expected, the mismatched target DNA 
showed lower fluorescence intensity than perfect matched target upon addition of 
FAM-PNA and GO (Figure 2.5a). Specifically, single bp mismatch in the middle 
of the upper target strand induced the decrease of the F/F0 value down to 57% 
compared to that from the perfect matched target DNA. Furthermore, the F/F0 
values decreased to ~35% with three bp mismatches, and down to below ~1% 
with scrambled dsDNA (in the mixture of 100 nM each target and 100 nM PNA 







Figure 2.5  Mismatch discrimination. a) Fluorescence spectra of PNA probe in 
the presence of target dsDNA, single base pair mismatched, three base pair 
mismatched dsDNA and scrambled sequence dsDNA with addition of GO. b) A 
bar graph showing fluorescence intensity enhancement (F/F0) with matched, 
mismatched dsDNA target (0, 50, 100 nM, respectively). 
 
 
Finally, we demonstrated the capability of multiple target detection in a 
single solution. We chose three target genes related to viral diseases for multiplex 
sensing: hepatitis A virus Vall7 polyprotein gene (HVA), human 
immunodeficiency virus (HIV) and hepatitis B virus surface antigen gene (HVB). 
Target dsDNAs having 15 bp with unique sequences derived from the three fatal 
viruses were then prepared and conjugated with three different fluorescent dyes—
FAM, ROX (6-carboxyl-X-rhodamine) and Cy5 (cyanine 5) which showed 
emission maxima of 518 (green), 608 (orange) and 670 nm (red) with excitation 
at 492, 587 and 650 nm, respectively. For multiple dsDNA detection, each target 
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mixture of the three dye labelled PNA probes (each concentration=100 nM), 
followed by addition of GO (Figure 2.6). 
 
Figure 2.6  Relative fluorescence intensity of each three dye labeled PNAs in 
the presence of GO. FAM, ROX and Cy5 was conjugated to each PNA probe for 
HVA, HIV and HVB, respectively. 
 
 
As expected, green, orange and red fluorescence emission spectra and images 
were obtained only in the sample containing each corresponding HVA, HIV and 
HVB target dsDNA (Figure 2.7). 

























Figure 2.7  Multiple target detection of three viral genes in a single solution. a) 
Fluorescence spectra of three dye labeled PNAs in the presence of 200 nM target 
dsDNA in a buffered solution. b) Fluorescent images of reaction mixtures for 
multiple detection. Column 1: fluorescence signal of FAM-HVA; Column 2: 
fluorescence signal of FAM-HVB; Column 3: fluorescence signal of FAM-HIV 
in the presence of 200 nM of each target. c) A bar graph showing relative 
fluorescence intensity of three dye labeled PNAs in the presence of each target 
dsDNA (200 nM) (F : fluorescence intensity of PNA probe with target, Fmax : 
Maximum fluorescence intensity of each PNA probe observed in the presence of 







In conclusion, we developed a new GO-based platform for direct and robust 
dsDNA detection using PNA probe. To the best of our knowledge, this is first 
study on sequence-specific, quantitative and direct detection of dsDNA based on 
GO. The present dsDNA sensor utilized the unique properties of PNA and GO. 
First, PNA could invade at the temini of the complementary strand of target 
dsDNA without sequence limitations, followed by strand replacement based on 
its higher binding affinity to complementary DNA than DNA probes. Second, GO 
showed outstanding adsorption ability for uncharged ssPNA compared to other 
biomolecules such as proteins and naturally occurring nucleic acids. Also, GO 
quenched the fluorescence of a dye that is attached to the PNA probe effectively. 
By combining PNA probe with GO, quantitative fluorometric dsDNA sensing 
was enabled even in the serum containing samples without a wide variation of 
LOD, which was impossible to achieve by using DNA probe. This combination 
of PNA and GO overcome drawbacks of conventional DNA or RNA probes and 
thus, would make the applicable field of GO based sensors broader. We believe 
that this new direct GO-based dsDNA sensor using PNA probe will become an 
important tool in the field of personalized medicine and diagnostics of viral 






2.4 Material and Methods 
Materials.   Graphite nanofibers was purchased from Catalytic Materials LLC 
(USA). Sulfuric acid (H2SO4) was purchased from Samchun chemical (Seoul, 
Korea). Hydrogen peroxide (30% in water) (H2O2) was purchased from Junsei 
(Japan). Potassium permanganate (KMnO4), Potassium persulfate (K2S2O8) and 
Phosphorus pentoxide (P2O5) were purchased from Sigma-Aldrich (MO, USA). 
Fatal bovine serum (FBS) was purchased from Welgene (Daegu, Korea). DNA 
strands were purchased from Genotech (Daejeon, Korea). PNA probes were 
purchased from Panagene (Daejeon, Korea). Fluorescence intensity and 
fluorescence image were obtained by fluorometer SynergyMx (Biotek, UK). 
 
Preparation of graphene oxide.   Graphene oxide (GO) was synthesized by 
using Hummers method with pre-oxidation treatment, using graphite nanofiber as 
starting material. First, concentrated H2SO4 (5 ml) was heated to 80 °C in a round 
bottom flask, then K2S2O8 (0.15 g) and P2O5 (0.15 g) were added in a round 
bottom flask, keeping at 80 °C for 4.5 hours. After the mixture was cooled, the 
reaction mixture was diluted with deionized (DI) water. This solution was filtered 
and rinsed with DI water (100 ml) for removing remained reactants. Obtained 
pre-oxidized graphite nanofibers were dried in air. Then, the dried solid was 
transferred into a 50 ml round bottom flask and concentrated H2SO4 was added 




added to the mixture slowly with stirring, keeping the temperature below 10 °C. 
After mixing, the flask was placed in 35 °C water bath for 12 hours. The mixture 
was transferred into an Erlenmeyer flask (500 ml) in an ice bath. DI water (100 
ml) was added to the flask slowly with stirring. During this step, keeping the 
temperature below 55 °C was needed. After that, 5 ml of 30 % H2O2 solution was 
added to the mixture, of which the color turned into bright yellow. This mixture 
was collected, centrifuged and then, rinsed with 3.4% HCl solution and acetone to 
get rid of residual salts and acid. Obtained solid GO was dried under vacuum 
before use. To get the GO solution, GO was dissolved in water, then the solution 
was centrifuged at 3000 rpm for 30 min to remove large chunks. 
 
Sequence information. 
DNA strands for mismatch discrimination:  




5’ ATA AGC GTA ACT TCC CTC AAA 3’ 5’ TTT GAG GGA AGT TAC GCT TAT 3’ 
Single bp 
mismatched 
5’ ATA AGC GTA TCT TCC CTC AAA 3’ 5’ TTT GAG GGA AGA TAC GCT TAT 3’ 
Three bp 
mismatched 
5’ ATA AGC GAA TCT ACC CTC AAA 3’ 5’ TTT GAG GGT AGA TTC GCT TAT 3’ 
Scrambled 
dsDNA 






DNA strands for multiplex dsDNA detection: 
 Upper strand Bottom strand 
HVA 5’ TTA GAG TTG CAT GGA 3’ 5’ TCC ATG CAA CTC TAA 3’ 
HIV 5’ TAA CAT GAC CTG GAT3 5’ ATC CAG GTC ATG TTA 3’ 
HVB 5’ ATG GAT GAT GTG GTA 3’ 5’ TAC CAC ATC ATC CAT 3’ 
 
PNA probes 
PNA probe (21mer) 5’  FAM - TTT GAG GGA AGT TAC GCT TAT 3’ 
HVA probe (15mer) 5' FAM - TCC ATG CAA CTC TAA 3' 
HIV probe (15mer) 5' ROX - ATC CAG GTC ATG TTA 3‘ 
HVB probe (15mer) 5' Cy5 - TAC CAC ATC ATC CAT 3' 
 
Detection of dsDNA using Peptide Nucleic Acid and Graphene Oxide.   
To prepare duplex DNA target, 2.5 μL of 100 μM upper strand DNA was mixed 
with and a 1.1-fold excess of bottom strand DNA in pH 8.0 buffer containing 50 
mM Tris-HCl and 50 mM NaCl. Then, the mixture was annealed by heating to 90℃ 
for 5 min and followed by slow cooling at room temperature for 1 hr. For dsDNA 
detection, reaction mixture was prepared by 100 nM FAM labeled PNA probe 
incubated with various concentration of annealed target dsDNA in 1XPBS 
containing BSA (pH 7.2 buffer containing NaCl 137 mM, KCl 2.7 mM, BSA 
0.01%). After incubation at room temperature for 1hr, 1 μL of 500 μg/ml GO 




Multiple target detection using Peptide Nucleic Acid and Graphene Oxide. For 
multiple target detection, dsDNA target was incubated with the PNA probes 
mixture containing each 10 pmol of FAM-HVA probe, ROX-HIV probe and Cy5-
HVB probe in 1XPBS. After incubation at room temperature for 1hr, 1.25 μL of 
500 μg/ml GO stock was added to mixture. FAM-PNA, ROX-PNA and Cy5-PNA 
were excited at 492 nm, 587 nm and 650 nm in a homogeneous solution. 
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3. Bovine Serum Albumin: A Simple Strategy for 
Practical Applications of PNA in Bioanalysis 
 
3.1  Introduction 
Peptide nucleic acid (PNA) is a DNA mimic composed of natural nucleobases 
and pseudo-peptide backbone.1,2 Being a polyamide based molecule, PNA 
exhibits high thermal/chemical stability as well as resistance to nuclease-
mediated degradation. In addition, the electrically neutral backbone enables PNA 
to hybridize with complementary DNA or RNA with high affinity and specificity. 
Therefore, PNA can be employed as not only a potent tool for molecular biology 
and genetic diagnostics, but also a powerful anti-sense drug candidate. Recently, 
many researchers demonstrated various nanomaterial based biosensors in 
combination with PNA.3-6 For example, a graphene oxide (GO) based sensing 
system using PNA probe was developed for target specific bio-detection, enzyme 
activity assay, duplex nucleic acid detection as well as live cell imaging of 
biomolecules.6-10 However, despite of a lot of merits of PNA, its applications 
have been limited by its poor solubility in aqueous solution which induces self-
aggregation or nonspecific adsorption on hydrophobic solid supports that are 
commonly used in biological applications such as polystyrene (PS) plates and 
plastic tubes.2,11 Generally, a mixed solution of PNA and solvent should be heated 




concentrations prepared for working solutions easily loses its function since the 
PNA in diluted solutions get adsorbed on vessel walls over time. Thus, to enhance 
the solubility of PNA and prevent self-aggregation, many approaches have been 
developed such as direct backbone modifications or conjugation of solubility 
enhancers utilizing charged amino acids, hydrophilic linkers or natural nucleic 
acids.12-15 Moreover, organic solvents such as dimethylformamide and dimethyl 
sulfoxide have been used for dissolving PNA.16-18 However, apart from the self-
aggregation of PNA, nonspecific adsorption of PNA on hydrophobic support has 
been relatively overlooked during PNA applications and could not be adequately 
overcome with structural modifications of PNA or usage of organic solvents. In 
addition, the excessive modifications or the high volume ratio of organic solvents 
could induce poor performance of PNA and other side effects in biological 
experiments.19,20 
Here, we employed bovine serum albumin (BSA) as an additive to prevent 
the nonspecific adsorption of PNA on a hydrophobic surface and to enhance its 
solubility in aqueous media and thus, improved the yield of target-specific 
hybridization (Scheme 3.1a). BSA is one of the serum albumin proteins, which is 
widely used blocking agent due to its high efficiency, cost effectiveness and 
biocompatibility in various bioanalytical experiments.21 Because BSA has both 
hydro-phobic and hydrophilic parts on the surface, it can prevent nonspecific 




applications such as ELISA and immunoblottings.22-25 Therefore, the usage of 
BSA can be a simple, effective method as a remedy to reduce a main shortcoming 
of PNA. Furthermore, we extended the application of BSA to GO/PNA based 
oligonucleotide sensors to improve sensing performance by preventing the 
interaction between PNA/DNA duplex and GO as well as the adsorption of PNA 
on hydrophobic surface (Scheme 3.1b). 
 
 
Scheme 3.1  BSA blocking to a) prevent the nonspecific adsorption of PNA on 
hydrophobic surface and b) inhibit the adsorption of PNA/DNA duplex on GO 






3.2  Result 
In the present study, the degree of PNA adsorption on a hydrophobic surface was 
judged by monitoring changes in the fluorescence emission intensity of the dye-
labelled PNA in solution. In the PNA structure, ethylene glycol linker (O), one of 
the solubility enhancers, was utilized to minimize the possibility of self-
aggregation of PNAs as well as to give space between the fluorescein amidite 
(FAM) moiety and the PNA strand. The 200 nM F-PNA (5’ FAM–OO–TTT 
GAG GGA AGT TAC GCT TAT–3’) in a phosphate buffered saline (PBS, pH 
7.4) was prepared by dilution of a 100 μM F-PNA stock solution. The 
fluorescence intensity of the diluted F-PNA solution gradually decreased down to 
~18% of the original intensity over 5 hrs when the solution was incubated in a 96 
well black PS plate (Figure 3.1a,b). On the other hand, the intensity of F-PNA 
incubated with 0.01% BSA very slightly decreased for initial 1 hr and maintained 
at ~90% of initial intensity in the same PS plate. As a control, when DNA probes 
were used in place of PNA, the same trend, ~10% decrease of initial fluorescence 
intensity over time, was observed regardless of BSA addition (Figure 3.1c). The 
degree of fluorescence intensity decrease of F-PNA was dependent on BSA 
concentration and maximum prevention of nonspecific adsorption was observed 
above as little as 0.002% BSA (Figure 3.1e,f). The decay of fluorescence 




spectrum, suggesting that the decline of intensity could be due to the aggregation 























Figure 3.1  Prevention of PNA adsorption on hydrophobic surface by BSA. a) 
Fluorescence spectra and b) time-dependent relative fluorescence intensity of F-
PNA in buffered solution containing BSA 0 % and 0.01 %. c) Time-dependent 
relative fluorescence intensity of F-PNA and F-DNA in buffer solution containing 
BSA 0% and 0.01%. d) Fluorescence spectra of F-PNA in buffer solution 
containing 0% and 0.01% BSA. The emission spectum of PNA solution without 
BSA was shifted by about 4 nm to red, whereas PNA solution with BSA didn‘t 
show the emission shift even after 12hr incubation. e) Fluorescence spectra and f) 




   To investigate the adsorption of F-PNA on the surface, we compared the 
fluorescence signal from the container wells (96 well black plate) before and after 
removing the F-PNA solution following 3 hrs incubation. In the case of F-PNA 
solution omitting BSA, the similar fluorescence intensity to the incubated 
solution was measured in the vacant container even after transferring out the 
solution and several washing. However, F-PNA solutions with BSA showed 
much lower fluorescence intensity from the empty container, BSA concentration 
dependently, after removing the solution. The tendency was also correlated with 










Figure 3.2  BSA concentration dependent blocking effect on hydrophobic 
surface. a) Fluorescence spectra of F-PNA incubated in a buffered solution 
containing BSA for 3 hr. The incubated PNA solutions were transferred to new 
containers and the emptied containers were washed with PBS twice. Fluorescence 
spectra of b) vacant containers and c) transferred supernatant. d) Fluorescence 
images of PNA solution, vacant container and transferred supernatant in the 
presence of various concentration of BSA. e) AFM images showing the gradient 
adsorption of BSA on polystyrene surfaces when polystyrene coated wafers were 




   The result indicated that the nonspecific adsorption of PNA on hydrophobic 
surface can be prevented by BSA blocking. Furthermore, a post-addition of BSA 
to the adsorbed F-PNA on the hydrophobic support resulted in the gradual 
recovery of fluorescence intensity until the equilibrium was reached, indicating 
that BSA could induce desorption of the F-PNA from a solid surface into the 
solution as well as the inhibition of the adsorption of F-PNA to a solid surface 
(Figure 3.3).  
 
 
Figure 3.3  PNA strand desorption by BSA. a) Time-dependent fluorescence 
recovery from non-specifically adsorbed PNA on the hydrophobic surface upon 
addition of BSA. b) Fluorescence spectra of F-PNA after 100 min from the BSA 
addition. 
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   Next, we utilized GO for identifying how much percentage of PNA strands 
were available as a probe in a hydrophobic container in the presence of BSA. GO, 
a water-dispersible graphene derivative, having a hexagonal lattice of sp2 carbons 
and oxygen containing functional groups was pre-pared by using a modified 
Hummers method.26-29 GO has high affinity to hydrophobic molecules as well as 
efficient fluorescence quenching of dyes near its surface.7,30,31 Thus, the 
nucleobases of single stranded PNA (ssPNA) can be adsorbed on the GO surface, 
inducing the fluorescence quenching of the dye conjugated to PNA. Upon the 
addition of GO to F-PNA solutions incubated in a hydrophobic container without 
and with 0.01% BSA showed the decrease in the fluorescence intensity, 







Figure 3.4 ssPNA strands in solution in the presence of BSA. Fluorescence 
spectra of F-PNA a) in buffered solution and b) in BSA containing buffered 
solution, in the presence of GO. c) Fluorescence spectra of F-PNA, F-PNA/DNA 
duplex, F-PNA with scramble sequenced DNA and F-PNA with BSA in buffered 
solution. d) Comparison of fluorescence spectra of F-PNA with the addition of 
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   We could assume that each percentage represented the proportion of ssPNA 
in each solution that was able to interact with GO, exhibiting exposed bases, and 
that the PNA adsorbed on the hydrophobic surface cannot function as a probe for 
hybridization. To examine capability of F-PNA for sequence specific 
hybridization with target nucleic acid, we next per-formed an experiment in 
which equal molar amount of complimentary DNA (cDNA) was added before 
and after F-PNA incubation in a hydrophobic container. The pre-hybridized F-
PNA/DNA duplex was highly soluble due to the polyanionic backbone of DNA 
and maintained the almost uniform fluorescence intensity, which was nearly 
identical with F-PNA solution containing 0.01% BSA. However, the F-PNA 
solution that was incubated in the container for 2 hrs, followed by the addition of 
cDNA, showed much lower fluorescence intensity compared to the pre-
hybridized F-PNA/DNA duplex (Figure 3.4c,d). These results suggested that the 
adsorbed F-PNA on a hydrophobic support cannot play a role as a probe for 
hybridization with complementary tar-get sequence. 
   To further investigate the problems occurred by nonspecific adsorption of 
PNA in biosensor application, we carried out a dsDNA detection using GO and 
PNA probe in the presence of BSA on the basis of end invasion of PNA to-wards 
dsDNA (Figure 3.5).10  In this method, a dye labeled PNA probe was incubated 
with target dsDNA for the formation of PNA/DNA duplex, followed by GO 




quenching of the dye conjugated to PNA. In contrast to BSA containing samples, 
BSA free sample showed a high background signal and target concentration 
independent F/F0 values, presenting the unfeasibility of dsDNA detection without 
BSA. This result indicated that nonspecifically adsorbed dye-labeled PNA could 
give high background signal in a fluorometric biosensing platform.  
 
Figure 3.5  Direct dsDNA detection using PNA probe in the presence of 0 and 
0.01% BSA. F/F0 values were shown above the corresponding bar graph. For 
direct dsDNA detection using PNA probe, a mixture was prepared by adding 10 
pmol FAM labelled PNA probe to annealed target dsDNA in PBS containing 0 
and 0.01% BSA. After incubation at room temperature for 1hr, 1 μg of GO was 
added to the mixture for adsorption of ssPNA on GO surface and fluorescence 
quenching. BSA free sample represented high background signal and unfeasibility 
of dsDNA detection. On the other hand, BSA containing sample showed 
negligible background signal and target concentration dependent F/F0 values, 































   We next performed an experiment to reveal BSA effect on the adsorption of 
F-PNA on a hydrophobic solid surface by varying the concentration of F-PNA. 
Lower concentration of F-PNA showed more significant decreases in 
fluorescence intensities after incubation in the absence of BSA. It indicated that 
the portion of adsorbed F-PNA was higher with low concentration of F-PNA on 
the hydrophobic support probably due to the relatively larger surface contact area 
per PNA. However, the F-PNA solution containing BSA maintained the 
fluorescence signal over 80% of initial intensity regardless of F-PNA 
concentration (Figure 3.6a). Because the concentration of F-PNA probes used in 
actual experiments is usually in nanomolar range, simply adding 0.01% BSA to a 
PNA solution can be very useful to various F-PNA applications by preventing the 
adsorption of PNA on a hydrophobic support. To be practical, it will be more 
convenient if a concentrated stock solution of PNA is made as a mixture with 
BSA at a proper concentration and used directly for dilution to make each 
working solution since additional pi-petting of BSA solution for each sample 
every time could be cumbersome and inefficient. We found that the 100-fold 
diluted F-PNA solution from the 20 μM F-PNA stock solution containing 0.5% 
BSA exhibited a constant fluorescence intensity without notable decrease in 





Figure 3.6  Further utility of BSA in PNA applications. a) Relative fluorescence 
intensity (F0 min = 1) of various concentrations of F-PNA with and without 0.01% 
BSA. b) Time dependent fluorescence intensity of three types of PNAs (20 nM), 
PNA1: diluted from a 20 μM PNA stock, PNA2:  diluted from a 20 μM PNA 
stock, followed by addition of BSA, PNA3: diluted from 20 μM PNA stock con-
taining 0.5% BSA. 
 
 
   We then investigated the sequence-specific tar-get DNA binding ability of F-
PNA probe with varying concentrations of BSA. The PNA/DNA duplex was first 
prepared by mixing equal molar amount of both strands in a buffered solution 
containing various concentrations of BSA. The duplex was characterized by using 
non-denaturing poly-acrylamide gel electrophoresis (native-PAGE). Due to less 
negative charge of F-PNA/DNA duplex compared to DNA/DNA duplex, the 
band of hetero duplex appeared at upper region showing slower migration than 
DNA duplex in the gel. The functionality of F-PNA wasn’t affected by BSA even 
though the concentration of BSA was raised up to 1% in F-PNA solution (Figure 
PNA (nM)












































3.7a). The co-incubation of F-PNA with BSA in a stock solution was similarly 
effective in pre-venting F-PNA adsorption with the typical blocking method in 
that a high concentration of BSA is treated on the support and rinsed away before 
assay. Both of the methods allowed much higher fluorescence of F-PNA 
compared to F-PNA solution without BSA, regardless of the type of surface 
materials (Figure 3.7b). Taken together, we found that BSA in a PNA stock 
solution can play an important role in a simple and practical usage of PNA. 
 
 
Figure 3.7  Effect of BSA on PNA functionality and other kinds of hydrophobic 
surface. a) Gel electrophoresis was performed on a 15% polyacrylamide gel. 
Lanes 1-4 show ssPNA, dsDNA, ssDNA (bottom strand) and ssDNA (upper 
strand). Lanes 5-7 show the hybridization of 10 pmol of PNA with equal molar 
amount of cDNA in the presence of various concentrations of BSA (1, 0.1, and 
0.01 %). Lanes 8-10 show 10 pmol of PNA incubated with 10 pmol of scDNA in 
the presence of various concentrations of BSA (1, 0.1, and 0.01 %). b) Relative 
fluorescence intensity of F-PNA (FPNA+BSA = 1) on three different types of 
surfaces, PA 1: polystyrene surface, PA 2 : physically treated polystyrene surface 
for cell culture, PP: polypropylene surface. Pre-BSA coated surface was prepared 
by incubation of the corresponding surface with 1% BSA for 1hr, followed by 




   We extended the application of BSA blocking to GO based sensing system 
using PNA. The fluorometric bioensing system was built on the preferential 
binding of GO to ssPNA over PNA/DNA duplex and the fluorescence quenching 
capability of GO.6-9  In case of the duplex, the nucleobases are shielded within 
negatively-charged DNA backbone and thus, they existed preferentially apart 
from GO. However, unfavorable experimental conditions such as very high 
concentration of GO or presence of divalent metal ions can cause the nonspecific 
adsorption of the duplex on GO surface.32-34 As a result, the target responsive 
fluorescence signal gets lower, resulting in poor performance as a sensor. 
Therefore, it is necessary to minimize the adsorption of the duplex on GO as well 
as adsorption of PNA on a hydrophobic support for better efficiency. Because GO 
is known to have affinity for various proteins including BSA due to its 
amphiphilicity,35,36 we applied BSA in GO/PNA sensing system to prevent the 
adsorption of the PNA/DNA duplex on GO (Scheme 5.1b). The interaction of 
BSA on GO was first confirmed by using isothermal titration calorimetry (ITC) 










Figure 3.8  Isothermal titration calorimetry (ITC) analysis of GO (0.08 mg/ml) 
with a) BSA (each 15 μL of 1 mg/ml) and b) PBS as a negative control. The top 
panels show raw data of the heat pulses resulting from each titration, whereas the 
bottom panels show the integrated heat normalized per weight of injectant (BSA 
or 1X PBS) as a function of the weight ratio.  
 
 
   We then compared the adsorption of ssPNA and PNA/DNA duplex onto GO 
surface in the presence of BSA to verify the selective blocking of the adsorption 
of PNA/DNA duplex. We measured the degree of fluorescence quenching of F-
PNA and F-PNA/DNA duplex with varying GO concentrations in the absence of 
and in the presence of 0.01% BSA. The concentration of BSA which maximized 





Figure 3.9  BSA dose-dependent relative fluorescence intensity of F-PNA and 
F-PNA/DNA duplex in the presence of GO.  
 
 
   In case of 10 pmol F-PNA, 0.10 and 0.13 μg of GO were required to quench 
the 50% fluorescence signal in a buffered solution without BSA and with BSA, 
respectively. However, F-PNA/DNA duplex (10 pmol) required 3.9 μg of GO for 
quenching the 50% fluorescence signal in a BSA containing buffered solution 
whereas 1.0 μg of GO was needed in a buffered solution omitting BSA (Figure 
3.10a). It is notable that BSA in PNA/GO based sensor prevents the adsorption of 
PNA/DNA duplex on GO surface while it has little effect on the interaction 
BSA (%)





















between ssPNA and GO surface. We then calculated the FPNA/DNA/FPNA at 
varying concentrations of GO to confirm the improved efficiency of the GO 
based sensor by BSA. When BSA was added in the PNA/GO mixture, the 
histogram of FPNA/DNA/FPNA shifted toward slightly higher GO concentration. 
However, meaningful values of FPNA/DNA/FPNA were obtained in much 
broader range of GO and a higher maximum value of FPNA/DNA/FPNA was 
observed in the presence of 0.01% BSA, indicating that BSA enabled the sensor 
to detect the target DNA with higher sensitivity in wider range of GO 










Figure 3.10  Signal enhancement by BSA in sensing platform using GO and 
PNA probe. a) GO concentration-dependent fluorescence intensity of F-PNA and 
F-PNA/DNA duplex in a buffered solution with or without 0.01% BSA. b) GO 
concentration-dependent FPNA-DNA/FPNA. c) Mg2+ concentration-dependent 
relative fluorescence intensity of F-PNA/DNA duplex in the presence of GO. d) 
Fluorescence recovery of F-PNA/GO upon addition of target DNA in a buffered 
solution containing 2.5 mM Mg2+ and BSA. Fluorescence spectra of PNA/GO 
upon addition of various concentration of target DNA in the presence of e) BSA 
0%, GO 1 µg and f) BSA 0.01%, GO 1.5 µg in a buffered solution containing 2.5 
mM Mg2+.  
MgCl2 (mM)
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   The BSA effect for selective blocking of GO could also be verified by 
elevating the concentration of metal ions in sensing condition. Divalent cations 
such as Mg2+ and Ca2+ required for various biofunctions generally facilitate the 
ad-sorption of PNA/DNA duplex onto the GO surface by neutralizing the 
electrostatic repulsion between the duplexes and GO. However, addition of BSA 
to GO in a solution containing Mg2+ prevented the adsorption of the duplex on 
GO and thus, the fluorescence of the dye conjugated to PNA did not diminish 
over time even under high concentrations of Mg2+ (Figure 3.10c). Next, we 
carried out DNA detection in a buffered solution containing 2.5 mM MgCl2 in the 
presence of BSA. Under the condition, the sensor with BSA exhibited a detection 
limit of 0.5 nM according to the equation, LOD = 3.3 (SD/S), which was 90-fold 
lower than that of the conventional PNA/GO based DNA sensing system omitting 












3.3  Conclusion 
In summary, BSA was employed in PNA application to enhance the stability of 
PNA in hydrophobic containers and improve the sensing performance of 
GO/PNA based DNA sensor. Although PNA has favorable properties such as 
higher chemical/biological stability, specificity and binding affinity for target 
nucleic acids compared to natural nucleic acid probes, its application has been 
limited due to nonspecific adsorption on hydrophobic surface. By incorporating 
0.01% BSA in a PNA solution, the adsorption of PNA on hydrophobic surface 
was easily prevented and the portion of the effective PNA strands for target 
binding could be in-creased without any disturbance on hybridization with a 
complementary target. Moreover, high concentration of BSA in a PNA stock 
showed same effect in preventing the nonspecific adsorption during the usage of 
diluted PNA stock. Also, in the GO based biosensor using PNA, BSA interrupted 
the unfavorable adsorption of PNA/DNA duplex on GO surface, while allowing 
the adsorption of ssPNA. The selective blocking on GO can improve the 
performance of the system by reducing the detection limit by 90-folds. This work 
is the first to utilize BSA for high yield of available PNA in its application by 
preventing the nonspecific adsorption and for signal enhancement in GO/PNA 
based sensor sys-tem. We believe that the present study will provide great 
opportunity to widen PNA application as useful tools in basic life science and 




3.4  Material and Methods 
Materials.   Bovine serum albumin (BSA) was purchased from Bovogen 
Biologicals (Victoria, Australia). DNA strands were purchased from Genotech 
(Daejeon, Korea). Dye labeled peptide nucleic acid (F-PNA) strand (5’- FAM-
OO- TTT GAG GGA AGT TAC GCT TAT -3’) was purchased from Panagene 
(Daejeon, Korea). Dye labeled DNA (F-DNA) strand (5’- FAM-TTT GAG GGA 
AGT TAC GCT TAT -3’), complementary DNA strand (5’- ATA AGC GTA ACT 
TCC CTC AAA -3’) and scrambled sequenced DNA strand (5’- TAG CTT ATC 
AGA CTG ATG TTG A -3’) were purchased from Genotech (Daejeon, Korea). 
Microtube was purchased from Axygen (Tewksbury, USA). 96 well black plate 
was purchased from SPL (Pocheon, Korea). 96 well cell culture plate with the 
physical surface treatment was purchase from Greiner Bio-One (Frickenhausen, 
Germany). Fluorescence intensity and fluorescence image were obtained by a 
fluorometer SynergyMx (Biotek, UK).  
 
DNA detection using PNA and Graphene Oxide in the presence of BSA.  
To prepare PNA/GO complex, 20 pmol of PNA strand was incubated with GO 1 
μg in 30 μl of PBS (pH 7.2 buffer containing 137 mM NaCl, 2.7 mM KCl) 
containing 0 or 0.01% BSA for 30min. Then, 30 μl of various concentrations of 
DNA target in PBS were added to the mixture. After incubation at room 
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4. A New Strategy for Nucleic Acid Detection with High 
Sequence Specificity Using Graphene Oxide and Peptide 
Nucleic Acid 
 
4.1  Introduction 
Nucleic acid detection is a crucial tool in clinical diagnosis and monitoring of the 
viral infection,1 cancer2 and diseases associated with genetic alterations. 3 In 
general, most of the detection methods such as blotting methods, 4 fluorescence in 
situ hybridization (FISH),5 polymerase chain reaction (PCR)6 and DNA 
microarray7 were based on the sequence specific recognition by using single 
stranded nucleic acid as a probe, through Watson-Crick base paring. 
Fundamentally, the hybridization of probe and target occurs with sequence 
specificity, but one or two nucleotide substitution in target is insufficient for 
discrimination of the mismatched target from corresponding perfect matched 
target. A single mismatched base pair (bp) within DNA duplex shows decreases 
of melting temperature (Tm) less than 3 ℃.8   
Precise recognition of few base differences in sequences having very high 
sequence similarity is important because it provides information on genetic 
mutation,9 DNA damage10 and single-nucleotide polymorphism (SNP).11 




artificial probes were introduced in many sensor systems.12 For examples, peptide 
nucleic acid (PNA) has neutral amide bond instead of phosphate backbone, which 
enables PNA to form highly stable duplexes with complementary target with high 
specificity in short time.13 Locked nucleic acid (LNA) possessing a methylene 
bridge between the 2′-oxygen of ribose and the 4′-carbon also represents strong 
affinity to target as well as high sequence specificity.14 Typically, a single 
mismatched bp in hybrid duplex of artificial probe and natural target causes 
greatly lower binding affinity, resulting in a wide decline of Tm upto 15 ℃. 8,15 
The larger gap of Tm compared to natural probes allowed nucleic acid detection 
with high sequence specificity. In the modified probe used sensing systems, 
discrimination of one or more mismatches is commonly achieved by adjusting the 
hybridization condition such as temperature, ionic strength or formamide 
concentration, or dissociation conditions of the probe and target duplex.16  
However, most of these systems should be performed by careful design of probe 
and optimizing the complicated discriminating condition.  
We therefore have suggested a new simple strategy for nucleic acid detection 
with extremely high sequence specificity using graphene oxide (GO) and PNA. 
GO,17 a water-soluble derivative of graphene, has been recently harnessed in 
diverse biological applications such as drug delivery,18 catalysis,19 enzyme 
activity assay20 and biosensor.21 General strategy in these applications relies on 




with GO through pi-pi stacking and/or hydrogen bonding interactions and the 
fluorescence-quenching capability of GO. As a probe, we chose PNA probe, one 
of the artificial nucleic acid for high sequence specificity. Addition to the widely 
known properties described above, PNA could also interact with negatively 
charged GO stronger than negatively charged nucleic acids and construct stable 
PNA/GO complex, thus the combination of PNA and GO has come into a 
spotlight in the field of biological application.22  
In this study, the highly efficient discrimination of single nucleotide 
substitution was achieved by eliminating the false signal generated from pre-
hybridized duplex of PNA and mismatched target. Upon incubation of fluorescent 
dye conjugated PNA with totally or partially complementary RNA in a solution, 
the PNA/RNA duplex was formed in a few minutes and the hybridization yield 
was inversely proportional to a number of mismatched pair and the site. By 
elevating the temperature of a hybridized PNA/RNA duplex in the presence of 
GO, the thermo-unstable duplex with mismatched target was relatively denatured 
and the temporarily dissociated ssPNA from mismatched target was adsorbed on 
GO. Finally, fluorescence signal for mismatched target was quenched by GO and 
only FAM-PNA maintaining the hybridization with perfect matched target 

























4.2  Result   
To demonstrate our strategy, we chose three RNA in let-7 miRNA family, let-7a, 
let-7c and let-7f RNA, as a perfect matched (PM) target and two types of single 
mismatched (SM) targets, respectively. let-7 miRNA family members are 
conserved across diverse animals in sequence and function, and its abnormal 
expression leads to a less differentiated cellular state and the development of cell-
based diseases such as cancer. 24 let-7c RNA (5’- UGA GGU AGU AGG UUG 
UAU GGU U -3’) and let-7f RNA (5’- UGA GGU AGU AGG UUG UAU GGU 
U -3’) have each one nucleotide substitution from let-7a RNA (5’- UGA GGU 
AGU AGG UUG UAU AGU U -3’) in different site, thus they are suitable model 
nucleic acid targets for evaluating the discrimination of single nucleotide 
substitution as well as interesting biomarkers for sensor system (Figure 4.1a). We 
then prepared carboxyfluorescein (FAM) labeled ssPNA probe of which sequence 
was fully complementary to let-7a RNA (FAM–-AAC TAT ACA ACC TAC 
TAC CTC A) and determined the optimal GO concentration for quenching the 
fluorescence of FAM-PNA probe. We found that the fluorescence of FAM-PNA 
probe (10 pmol) was quenched up to ~98% in the presence of GO (0.1 μg), giving 





Figure 4.1  Fluorescence quenching of dye conjugated to PNA by GO. a) 
Sequences of target miRNA and FAM conjugated let-7a PNA probe. b) Relative 
fluorescence intensity and c) spectra of FAM conjugated to PNA in the presence 
of GO. The fluorescence signal of 10 pmol of FAM coujugated PNA was 
quenched by 0.1 ug of GO.  
 
 
Before the introduction of the new strategy to GO based sensor system, we 
conducted nucleic acid detection using fluorescence quenched FAM-PNA by GO 
and synthetic RNAs to confirm the sequence specificity of conventional system. 
According to the protocol reported previously, the FAM-PNA probe was mixed 
with GO solution to construct PNA/GO complex, then each miRNA target was 
added. The fluorescence intensities of the mixtures were increased with all totally 
and partially complementary target (let-7a, let-7c and let-7f RNA), whereas 
which a mixture with scrambled RNA wasn’t. Upon addition of let-7c and let-7f 
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RNA, the fluorescence of FAM-PNA probe showed 53% and 73% of 
fluorescence recovery compared to let-7a RNA, respectively (Figure 4.2). This 
results indicated that the established nucleic acid sensing system wasn’t enough 
to use in the applications requiring extremely high sequence specificity such as 
miRNA profiling and SNP detection, unfortunately.  
 
Figure 4.2  Single mismatch discrimination using conventional GO based 
sensing system. a) Fluorescence spectra and b) F/Fc of FAM labeled let-7a 
probe/GO complex in the presence of various kinds of target 
 
 
Next, we carried out temperature dependent single mismatch discrimination 
test to optimize the temperature for dissociation of PNA from mismatched target. 
FAM-PNA was pre-incubated with three synthetic miRNAs in buffered solution 
for hybridization, and then GO was added to the duplex containing solution. The 
mixture was heated at high temperature (55 ℃ - 75 ℃) for 5 min to induce 
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dissociation of less stable PNA/RNA duplex and adsorption of ssPNA on GO. At 
room temperature without heating, let-7c and let-7f RNA were discriminated 
from let-7a RNA with only 80% and 69% efficiency. However, upon the heating 
at high temperature, the efficiency value was increased and it reached upto 96% 
at 70 ℃  (Figure 4.3a).  Under the experimental condition, high sequence 
specificity was confirmed by showing almost overlapped fluorescence spectra of 
mixtures containing let-7c, let-7F RNA with scrambled RNA (Figure 4.3b).  
 
Figure 4.3  Temperature dependent discrimination (RNA target). a) 
Fluorescence intensity of FAM labeled PNA probe in the presence of each 
miRNA after thermal dissociation step in a broad range of temperature in the 
presence of 0.1 µg of GO. The discrimination efficiencies (discrimination 
efficiency (%) =  100 X (F - Fscrambled)/(Fperfect matched-Fscrambled) ) of let-7a PNA 
probe against let-7c RNA (upper) and let-7f RNA (bottom) were described above 
the bar graphs.  b) fluorescence spectra of FAM conjugated PNA with target 
miRNA after thermal dissociation at 70 ℃ in the presence of 0.1 µg of GO.  
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We also repeated same experiment for temperature dependent discrimination 
using ssDNA targets possessing the same sequence with let-7a, let-7c, let-7f RNA 
but thymine in place of uracil. Screening of a wide range of dissociation 
temperature using DNA targets, optimized discrimination efficiency over 95% 
was obtained at 65 ℃, which is 5 ℃ lower than RNA targets (Figure 4.4). This 
shift of dissociation temperature was demonstrated by the previously reported 
result that Tm value of PNA/DNA duplex was 4 ℃ lower than PNA/RNA 
duplex.15 The data suggested that the present GO based platform is highly 
sensitive to Tm of duplexes and attractive for discrimination of small difference 














Figure 4.4  Temperature dependent discrimination (DNA target). a) 
Fluorescence intensity of FAM labeled let-7a PNA probe in the presence of each 
DNA target possessing let-7 miRNA family (d-let-7) after thermal dissociation 
step in a broad range of temperature in the presence of 0.1 µg of GO. The 
discrimination efficiencies of let-7a PNA probe against d-let-7c (upper) and d-let-
7f (bottom) were discribed above the bar graphs. b) fluorescence specra of FAM 
conjugated PNA with target DNA after termal dissociation at 70 ℃ in the 
presence of GO. 
 
 
Next, we performed quantitative fluorometric detection of target RNA with 
the procedure containing thermal treatment. Various concentrations of target let-
7a RNA solutions ranging from 0 to 100 nM were mixed with FAM-PNA probe 
and then, GO solution was added. The mixed solutions of RNA, FAM-PNA and 
GO underwent the thermal treatment step for selective dissociation at 70 ℃ for 
5 min. The fluorescence emission spectra of the mixture showed the RNA 
concentration dependent fluorescence enhancement (Figure 4.5a). This sensor 
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showed a linear fluorescence increase between 0 and 6.25 nM with the detection 
limit of 230 pM according to the equation, LOD = 3.3 (SD / S) (LOD: limit of 
detection, SD: standard deviation, S: slope of the calibration curve) (Figure 4.5b). 
 
 
Figure 4.5  Limit of detection test in buffered solution. a) Fluorescence spectra 
of PNA probe in presence of various concentration of let-7 miRNA in buffered 
solution. b) Fluorescence intensity enhancement (F/F0) with wide concentration 
range of target (F: fluorescence intensity of PNA probe with target, F0: 
fluorescence intensity of PNA probe without target). 
 
 
To investigate the applicability for highly sequence specific nucleic acid 
detection in serum containing biological samples, we carried out the same 
experiment using RNA spiked cell lysate (10000 cells per a sample). Under the 
established experimental condition, let-7a RNA couldn’t be totally discriminated 
let-7a RNA (nM)
































0 – 100 nM
b)a)
LOD = 0.23 nM











against single mismatched target, let-7c, let-7f RNA in a whole range of 
dissociation temperature (Figure 4.6).  
 
 
Figure 4.6  Temperature dependent discriminaiton of spiked miRNA in cell 
lysate. Fluorescence intensity of FAM labeled PNA probe in the presence of each 
spiked let-7 miRNA in HeLa cell lysate (10000 cells per well) after thermal 
dissociation step with broad range of temperature in the presence of 0.1 µg of GO. 
Although the signal of scrambled RNA was almost quenched, perfect matched 
target wasn‘t discriminated from mismatched target efficiently, even at high 
temperature.   
 
 
Thus, we examined higher concentraiton of GO for overcoming the 
disturbance of proteins in lysate for adsorption of dissociated ssPNA. As expected, 
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mixtures of FAM-PNA and RNA including 0.5 μg of GO showed high efficiency 
of discrimination over 95% (Figure 4.7a,b). The fluorescence emission spectra 
showed slightly higher fluorescence intensity compared to that from solutions 
prepared in 1XPBS with same conditions (Figure 4.7c). This finding agrees with 
previously reported result that proteins in GO based sensor system can enhance 
the target specific signal by blocking nonspecific adsroption of duplex selectively. 
Under the condition, the sensor also exhibited a linear fluorescence increase in 
the same concentration range of target RNA (0 ~ 6.25 nM) with a slightly higher 

















Figure 4.7  Single mismatch discrimination of spiked miRNA in cell lysates. a) 
Fluorescence intensity of FAM conjugated let-7a PNA probe in the presence of 
each spiked let-7 miRNA in HeLa cell lysate (10000 cells per well) after thermal 
dissociation at 70 ℃ in the presence of various amount of GO. Discrimination 
efficiencies of let-7a PNA probe against let-7c (upper) and let-7f (bottom) were 
described above the bar graphs.  b) Fluorescence spectra of FAM conjugated 
PNA with target miRNA after thermal dissociation in the presence of 0.5 µg of 
GO. c) Fluorescence spectra and d) Fluorescence intensity enhancement (F/F0) of 
PNA probe in presence of various concentration of spiked let-7a miRNA in HeLa 
cell lysate after thermal dissociation step in the presence of 0.5 µg of GO.  (F: 
fluorescence intensity of PNA probe with target, F0: fluorescence intensity of 
PNA probe without target).  
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Finally, we demonstrated the capability of multiplexed detection in a solution 
using RNA targets possessing only one nucleotide difference each other. We 
chose two sets of RNA targets, let-7a/let-7c RNA and let-7a/let-7f RNA. Each 
complimentary sequenced PNA probe for let-7a, let-7c and let-7f RNA was 
conjugated with three different fluorescent dyes—FAM, ROX (6-carboxyl-X-
rhodamine) and Cy5 (cyanine 5) which showed emission maxima of 518 (green), 
608 (orange) and 670 nm (red) with excitation at 492, 587 and 650 nm, 
respectively. For two kinds of RNA detection in a solution, each target RNA or a 
combination of two RNAs (200 nM) were added to the mixture of the each 
corresponding dye labelled PNA probes (each concentration= 100 nM), followed 
by addition of optimized amount of GO (Figure 4.8).  
 
Figure 4.8  Multi-probe quenching test in a solution. Relative fluorescence 
intensity of a) FAM-let-7a PNA probe and ROX-let-7c PNA probe, b) FAM-let-
7a PNA probe and Cy5-let-7f PNA probe in the presence of various amount of 










































Then, we screened the temperature from 65 ℃ to 75 ℃ with the interval of 
2 ℃ for 5 min to optimize the temperature for effective dissociation of two 
different PNA probe from mismatched target in a solution (Figure 4.9). 
 
 
Figure 4.9  Temperature dependent multiplex detection of a) let-7a and let-7c , 
b) let-7a and let-7f with each corresponding PNA probe in a solution after 
thermal dissociation step from 65 ℃ to 75 ℃ in the presence of GO. 
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• FAM‐7a‐probe  ( ex490 / em530) • ROX‐7c‐probe  ( ex575 / em600)




As a result, let-7a/let-7c RNA and let-7a/let-7f RNA were highly 
discriminated detection at 69 ℃ and 71 ℃, respectively. These tendency of 
optimized temperatures agrees with the order of Tm of each PNA probe with 
perfect matched target (82 ℃ for let-7c pair > 79 ℃ for let-7a pair > 76 ℃ for 
let-7f pair). At each optimized temperature, green, orange and red fluorescence 
emission spectra and images were obtained only in the sample containing each 
corresponding RNA target and PNA probe (Figure 4.10).  
 
Figure 4.10  Multiplex miRNA detection at each optimal temperature. A bar 
graph and fluorescence images showing relative fluorescence intensity of a) 
FAM-let-7a probe / ROX-let-7c probe, b) FAM-let-7a probe / Cy5-let-7f probe in 
the presence of each target miRNA (200 nM). (F: fluorescence intensity of PNA 
probe with target, Fmax: Maximum fluorescence intensity of each PNA probe 










































let-7a: UGA GGU AGU AGG UUG UAU AGU U 








let-7a: UGA GGU AGU AGG UUG UAU AGU U 




4.3  Conclusion 
In conclusion, we developed a new strategy for discrimination of single 
mismatched target using GO and PNA probe. To the best of our knowledge, this 
work provides the first example of highly effective single mismatch 
discrimination among a lot of GO based sensors. The present system utilized each 
remarkable properties of PNA probe and GO. First, PNA probe provides high 
binding affinity and sequence specificity to target due to its neutral backbone. 
The duplex of PNA probe with a single mismatched target was less stable than 
with perfect matched target, resulting in selective denaturation upon elevating the 
temperature. Second, GO acts as a scavenger for adsorption of ssPNA dissociated 
from mismatched target as well as a superquencher for the dye conjugated to the 
PNA. In addition, owing to the strong interaction between PNA and GO, 
quantitative miRNA detection with high sequence specificity was enabled even in 
the serum containing samples without a wide variation of LOD. The present 
sensor is technically straightforward and compatible with multiplexed sensing 
formats using sequentially similar targets. Many samples can be simultaneously 
prepared, and the quantitative multiplex detection with high specificity can be 
carried out by simply obtaining a fluorescence image of the samples after mixing 
and incubation at each optimized temperature without separation of mismatched 
RNA. Finally, this sensing platform can be applied to detection of point-




discrimination in other miRNA family by simply changing the sequence of PNA 
probe and optimizing the dissociation temperature. We believe that this new 
strategy for highly discriminating of single mismatch using PNA probe and GO 
will become an important tool in the basic research of nucleic acid and the field 




















4.4 Material and Methods 
Materials.   RNA strands were purchased from Bioneer (Daejeon, Korea). DNA 
strands were purchased from Genotech (Daejeon, Korea). PNA probes were 
purchased from Panagene (Daejeon, Korea). Temperature control was performed 
by using thermocycler (BioRad, USA). Fluorescence intensity and fluorescence 
image were obtained by fluorometer SynergyMx (Biotek, UK).  
 
Temperature dependent mismatch discrimination using peptide nucleic acid and 
graphene oxide.   Firstly, to prepare target/PNA probe duplex, 1 μL of 5 μM 
RNA target strand was mixed with 10 pmol of dye labeled PNA probe in pH 7.2 
1XPBS buffer containing NaCl 137 mM, KCl 2.7 mM, followed by incubation at 
room temperature for 10min. Then, 0.1 μg of GO was added to the mixture, 
followed by heating at high temperature (55 ℃ - 75 ℃) for 5 min to induce 
selective dissociation of relatively unstable duplex. After cooling down, 
fluorescence intensity of the mixture was measured.  
 
Multiplex detection of let-7a and let-7c possessing only one base difference 
between them.   For preparation of probe/target duplex, two RNA target strands 
(20 pmol) was incubated with FAM labeled let-7a probe and ROX labeled let-7c 
probe (each 10 pmol) in a 1XPBS solution for 10 min. Then, 0.3 μg of GO was 




dissociation of two kinds of relatively unstable duplex. After cooling down, 
fluorescence intensity of the mixture was measured at ex 492 nm/em 518 nm for 
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5. A Simple DNA Exonuclease Activity Assay Based on 
Graphene Oxide 
 
5.1  Introduction 
Exonucleases are DNA degrading enzymes by catalyzing hydrolysis of 
phosphodiester bonds from the 3' or the 5' end.1 They play pivotal roles in a 
variety of physiological and cellular processes. For example, DNA polymerases 
which catalyze the synthesis of nucleic acids on pre-existing nucleic acid 
templates have the exonuclease activity to mediate proofreading and DNA repair 
during DNA replication process.2  3’→5’ exonucleases are a class of this 
enzyme family, which remove nucleotides at the 3’ termini from DNA strands to 
prevent the formation of aberrant double stranded structure.3 They are directly 
involved in maintaining genome stability through the proofreading function 
during DNA replication. For example, TREX 1 which is the major 3’→5’ 
exonuclease in mammalian cells shows a proofreading role during lagging strand 
DNA synthesis or a gap filling role during DNA repair.4 Mutations in this gene 
cause serious diseases including chilblain lupus, retinal vasculopathy cerebral 
dystrophy (RVCL), Aicardi-Goutieres syndrome and Cree encephalitis.5-9 
Therefore, it is important to measure the enzyme activities for drug development 
and mechanistic study. Traditionally, gel electrophoresis and/or 32P labelled 




However, these assay methods are laborious, time/cost-consuming, and not 
suitable for high throughput assay. Recently, alternative approaches have been 
developed such as colorimetric and fluorescence methods based on nanomaterials 
for monitoring of exonuclease activity.12-14 
Here, we report a new 3‘→5‘ DNA exonuclease activity assay method based 
on graphene oxide (GO) (Scheme 1). Graphene, a single atomic layer carbon 
nanosheet, is an attractive material with extraordinary electronic, thermal, and 
mechanical properties.15  GO, a water-soluble derivative of graphene, has a great 
potential for biological applications, such as biosensors, and enzyme activity 
assays.16,17  Previously, GO was shown to interact with ssDNA through pi-
stacking interactions, whereas dsDNA cannot be effectively bound to the GO 
surface.18  Our strategy for exonuclease assay relies on the binding of 
fluorescently labeled ssDNA with GO and quenching of fluorescence by GO. To 
demonstrate our strategy, we use a hairpin-structured DNA substrate labeled with 
a fluorescent dye at 5’ end and exonuclease III (Exo III) which digests dsDNA, 
not ssDNA, specifically from the 3' terminus until dsDNA is depleted.19  This 
enzyme affords the dye-conjugated ssDNA from the hairpin-substrate, resulting in 






















5.2  Result  
First, we prepared an aqueous suspension of GO according to a modified 
Hummers method.20 The formation of the single layered GO sheet with ~ 1.4 nm 
thickness was confirmed by atomic force microscopy (AFM) image and the 
height profile (Figure 5.1a,b). Next, we characterized the GO using FT-IR and 
Raman spectroscopy. The FT-IR spectrum showed several characteristic peaks 
which suggest successful formation of GO, including peaks at 1625 and 1087 cm-
1 from C=C skeletal vibrations and C–O stretching, respectively (Figure 5.1c). 
The Raman spectrum of GO showed G band at 1598 cm-1 from the ordered sp2 
carbon domain, and D band at 1359 cm-1 which indicates the structural disorder 
of the sp2 carbon domain, induced by oxidation and exfoliation (Figure 5.1d). 
















Figure 5.1  GO characterization. a) AFM image and b) height profile of GO c) 
FT-IR and d) Raman spectra of GO, which present characteristic peaks 




   Next, a substrate DNA of Exo III was prepared by self-annealing the 
fluorescein amidite (FAM) labeled hairpin DNA sequence (5' FAM— 
GGCCGAGC TTTTTT GCTCGGCC – 3') (Figure 5.2a). The substrate DNA was 




and 1 mM dithiothreitol (Exo III reaction buffer, pH 7.0). Optimal GO 
concentration was determined by comparing the fluorescence intensity between 
the hairpin substrate DNA and the DNA product (ssDNA) generated by Exo III-
mediated hydrolysis, in the presence of the various concentrations of GO. We 
found that 5.5 μg/mL GO showed ca. 91% quenching efficiency, giving a 
maximum difference in fluorescence intensities between intact hairpin substrate 
DNA and product ssDNA produced by Exo III (Figure 5.2b) 
 
Figure 5.2  Fluorescence quenching of the FAM that is conjugated to ssDNA by 
GO. a) DNA sequence prepared for Exo III reaction is shown. DNA shows the 
hairpin structure consisting of 8-bp sequence at 5’-terminus and its 
complementary sequence at the 3’-terminus connected by a 6-bp flexible 
thymine-rich linker. b) Fluorescence spectra of hairpin DNA substrate and 
ssDNA product generated from Exo III-mediated digestion were obtained in the 
presence of GO (5.5 mg/ml).   
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   We then performed the time-dependent digestion of the hairpin DNA 
substrate catalyzed by Exo III. Reaction mixtures were prepared by adding 1 or 
0.125 U of Exo III to 30 μL of hairpin substrate solution in Exo III reaction buffer. 
Then, GO solution was added to the Exo III reaction mixture to make final 
concentration 5.5 μg/mL in a 96-well plate at 10 min intervals (Figure 5.3a). The 
fluorescence spectrum was then obtained from each well using a fluorometer. 
Enzyme concentration-dependent DNA hydrolysis assay was next performed 
using various concentrations of Exo III (Figure 5.3b). As expected, the DNA 
digestion proceeded faster with higher concentrations of Exo III. We next 
performed inhibition assays of Exo III using two known inhibitors to demonstrate 
that the present method was quantitative and applicable to the evaluation of 
inhibitors. Aurintricarboxylic acid (ATA) and ethylenediaminetetraacetic acid 
(EDTA) were chosen as Exo III inhibitors.21 Exo III (1 U) was added to hairpin 
substrate solution in the presence of various concentrations of the inhibitors, and 
incubated at room temperature for 30 min. Fluorescence spectra were obtained 
after mixing the reaction mixtures with GO solution. Dose-dependent inhibition 
curves were plotted based on fluorescence intensities. The IC50 values of ATA 







Figure 5.3  ExoIII activity assay. a) The time–dependent and b) enzyme 
concentration–dependent digestions of hairpin DNA substrate by Exo III were 
measured by obtaining fluorescence of the reaction mixtures. Dose-dependent 
inhibition of Exo III by c) ATA and d) EDTA were examined, and IC50 values 
were obtained.  
 
 
   Next, we carried out an experiment to compare a conventional method (gel 
electrophoresis) with the present GO-based method. In a typical method, the 
digested ssDNA and hairpin DNA are resolved using a urea-polyacrylamide gel 











































































































electrophoresis (Urea-PAGE). Exo III concentration-dependent DNA digestion 
was observed in both experiments (Figure 5.4a). In our GO-based assay, addition 
of GO led to the quenching of nuclease activity and allowed the simple and rapid 
detection of changes in fluorescence intensities. In contrast, the conventional gel-
based assay required two steps involving the quenching of enzymatic activities by 
adding EDTA and subsequently, running a gel to resolve the hairpin substrate and 
the digested ssDNA.  
   Finally, we demonstrated the feasibility of conducting parallel assays using 
our GO based platform by obtaining fluorescence images of multiple reaction 
mixtures. The samples were prepared by mixing the hairpin substrate solution 
with or without inhibitors and Exo III in a 96-well plate. As expected, the 
enzyme-treated samples without the addition of any inhibitor showed the lowest 
fluorescence, compared with the other samples (Figure 5.4b). Next, various 
concentrations of inhibitors were mixed with the hairpin DNA substrate followed 
by addition of Exo III stock solution. The fluorescence images obtained after 
addition of GO showed increasing fluorescence intensity as the concentration of 
inhibitors was raised. It was clear that our GO-based exonuclease activity assay 
method was compatible with parallel enzyme activity measurements, such as 








Figure 5.4  Fluorescence images for Exo III assay. a) Comparison between a 
conventional exonuclease assay method and the new method based on GO. Gel 
electrophoresis was performed as a conventional method to resolve DNAs 
according to the differences in length. Fluorometric assay based on GO showed 
the fluorescent images depending on the concentration of Exo III. b) Fluorescent 
images obtained from the inhibition assay of Exo III. Row 1: ATA inhibition, 
Row 2: EDTA inhibition of Exo III activity; c) Fluorescent images obtained from 
concentration-dependent inhibition assay. Row 1: ATA inhibition; Row 2: EDTA 










In conclusion, we developed the new GO based assay for 3’→5’ DNA 
exonuclease activity. This method utilized a DNA substrate with hairpin structure 
to prevent adsorption to GO before digestion. Degradation of the substrate by Exo 
III yielded ssDNA resulting in binding of ssDNA with GO and therefore, 
quenching of fluorescence. The present platform for exonuclease activity assay is 
more cost- and time-efficient compared to the conventional assay such as a gel 
based assay. In addition, this method is technically simple and compatible with 
parallel assay formats. Many samples can be prepared, and the quantitative 
analysis of their activity can be performed by simply obtaining a fluorescence 
image of the samples. Finally, this platform, based on GO, is versatile and can be 
applied to measure the activity of other classes of exonucleases by adjusting the 
structure of substrate DNA to corresponding enzymes. We expect that this assay 
platform will become an important assay tool in drug development and basic 










5.4  Material and Methods 
Materials.   Arintricarboxylic acid (ATA) were purchased from Sigma-Aldrich 
(MO, USA). Fluorescent dye labelled hairpin DNAs for Exo III substrate (5' 
FAM— GGCCGAGC TTTTTT GCTCGGCC – 3') was purchased from 
Genotech (Daejeon, Korea). Exonuclease III (Exo III) was purchased from New 
England BioLabs (MA, UK). Ethylenediamine tetraacetic acid (EDTA) was 
purchased from BIO-RAD (CA, USA). Fluorescence intensity was measured by 
fluorometer SynergyMx (Biotek, UK) 
 
Exo III activity assay by GO based platform.   To prepare hairpin structured 
DNA substrate of Exo III, 2.5 μL of 100 μM fluorescent dye labeled DNA in pH 
8.0 buffer containing 50 mM Tris-HCl and 50 mM NaCl was self-annealed by 
heating to 90oC for 5 min and followed by slow cooling at room temperature for 
1 hr. For Exo III activity assay, reaction mixture was prepared by mixing Exo III 
enzyme stock with 200 nM annealed DNA in 1X Exo III reaction buffer (pH 7.0, 
10 mM Bis-Tris Propane, 10 mM MgCl2, and 1 mM dithiothreitol). After 
incubation at room temperature for designated time, 30 μL of reaction mixture 
and 30 μL of 11 μg/ml GO solution were mixed in a 96-well plate. Fluorescence 





Exo III inhibition assay by GO based plarform.   For EDTA-Exo III inhibition 
assay, EDTA solutions with various concentrations were mixed with 200 nM 
DNA in 1X Exo III reaction buffer followed by addition of 1 Unit of Exo III. 
After incubation at room temperature for 30min, each 30 μL of reaction mixtures 
were mixed with 30 μL of 11 μg/ml GO solutions in a 96-well plate. In case of 
ATA-Exo III, ATA solutions with various concentrations were mixed with 200 nM 
DNA in 1X Exo III reaction buffer and followed by addition of 1 Unit of Exo III. 
After incubation at room temperature for 1hr, each 30 μL of reaction mixtures 
were mixed with 30 μL of 11 μg/ml GO solutions in a 96-well plate. Fluorescence 
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6. Robust and Quantitative Platform for Multiplexed 
Protein Kinase Inhibitor Screening 
 
6.1  Introduction  
Protein kinases are a family of enzymes that modifies proteins by transferring a 
phosphate group from ATP to serine, threonine or tyrosine residues in protein 
substrates.1 These kinase are involved in many important biological processes 
including cell growth, differentiation and apoptosis.2 Aberrations in protein 
kinase activity generally cause the development of severe diseases such as 
cancers, inflammations and diabetes. Therefore, evaluating the kinase activity and 
discovering its inhibitors are very important in the fields of clinical diagnosis and 
targeted therapy of related diseases.  
Generally, there are two typical methods for measuring the activity of protein 
kinase, radiometric assay3 using radioactive ATP with γ-32P, and immunoassay4 
using phosphospecific antibody for specific recognition of transferred phosphate 
groups. Although these assay methods are utilized routinely for analyzing protein 
kinase activity in most laboratories, these methods require labor-intensive 
procedures, expensive reagents or instrumentations. Recently, various techniques 
based on fluorescence,5 luminescence,6 electrochemistry7 or mass spectrometry 8 




Nanomaterial based approaches, based on above techniques, have been actively 
developed for simple and multiplexed monitoring of protein kinase activities.9   
Here, we report a robust protein kinase activity assay platform based on an 
affinity of phosphate group against TiO210 and fluorescence super-quenching 
ability of graphene oxide (GO) by energy transfer.11 Also, to demonstrate of the 
feasibility in drug discovery processes, the platform was utilized for protein 
kinase inhibitor screening. GO, a water soluble derivative of graphene, has been 
used in various bioapplications due to its unique mechanical, electronic, and 
optical properties as well as high biocompatibility.12  Especially, it has come 
into spotlight in the field of bioanalytical application due to high affinity to 
various biomolecules and selective quenching phenomena of fluorescent 
molecules which was in close proximity with GO surface.13 Various GO based 
analytical systems to detect various biomolecules such as DNA, protein and 
peptide have been reported since 2009.14  
In this study, we employed the super-quenching ability of GO to simple and 
robust kinase activity assay. To supply the lack of difference of binding affinity 
on GO between substrate and phosphorylated substrate, new hybrid material 
based GO was required to run the phosphorylation specific adsorption and 
fluorescence quenching. Titanium dioxide (TiO2) has been broadly used in metal 
oxide affinity chromatography (MOAC) in which phosphopeptide were bound 




particles was grown on the both side of GO sheets, resulting in TiO2 decorated 
GO sheet (TiO2-GO). Upon the phosphorylation of dye labeled substrate peptide 
by protein kinase, the phosphorylated product can be adsorbed on TiO2 GO and 
the fluorescence of dye conjugated on the peptide was quenched by nearest GO. 
Therefore, by measuring the change of fluorescence intensity, protein kinase 
activity can be analyzed simply and quantitatively. In this study, two protein 
kinase A (PKA) and extracellular signal regulated kinase 2 (ERK2) were used as 
representatives of protein kinase family (Scheme 6.1).  
 








6.2  Result  
First, we achieved TiO2-GO hybrid structure by growth of Ti(BuO)4 
nanoparticles on GO sheets. GO prepared by modified Hummers method16 
provided functional groups for anchoring sites for nucleation and growth of TiO2. 
By slowing down the rate of hydrolysis, the growth of TiO2 can be facilitated 
selectively on GO surface without formation of free TiO2 in solution. 17 The 
growth of TiO2 on GO was confirmed by atomic force microscopy (AFM) and the 
height profile showed that size of TiO2 particle was below 9 nm (Figure 6.1a). 
Next, the Raman spectrum showed peaks at 1352 and 1601 cm-1, which 
correspond respectively to the D band and G band of GO (Figure 6.1b). We 
further characterized the TiO2-GO using transmission electron microscope (TEM) 
and scanning transmission electron microscope (STEM), of which images 
confirmed TiO2 particles on GO (Figure 6.1c,d). Collectively, we confirmed that 













Figure 6.1  Characterization of TiO2-GO. a) AFM image and height profile of 
TiO2-GO. b) Raman spectrum of TiO2-GO with identified peaks with GO. c) 















The present strategy started with preparation of hydroxycoumarin labeled 
PKA substrate peptide (peptide 1: hydroxycoumarin-Leu-Arg-Arg-Ala-Ser-Leu-
Gly) and TAMRA labeled ERK2 substrate peptide (peptide 2: TAMRA-Gly-Gly-
Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg) by solid phase synthesis method.18 Both 
of peptide 1 and 2 were successfully phosphorylated by PKA and ERK2 in Tris-
HCl buffer solution (pH 7.4) containing MgCl2, and ATP, which were confirmed 
by MALDI-TOF analysis (Figure 6.2a,b). 
  
Figure 6.2  Chemical structures of a) 7-hydroxycoumarin conjugated PKA 
substrate peptide before and after PKA reaction, b) TAMRA conjugated ERK2 
substrate peptide before and after ERK2 reaction. The each mass spectrum 














Substrate (MW = 960.06 /M1)
a)
P-substrate (MW = 1039.03 /M2)
PKA
b)
















Then, we investigated the adsorption of phosphorylated peptide on TiO2-GO, 
followed by selective fluorescence quenching of dye conjugated to the product. 
To complement the specificity of phosphorylated peptide for selective adsorption 
on TiO2-GO, we utilized trifluoroacetic acid (TFA) and acetonitrile (ACN), 
which were known as interrupting the nonspecific adsorption of 
nonphosphorylated peptide on MOAC.15 As a result, the combination of TFA and 
ACN showed the best discrimination between substrate and phosphorylated 
peptide (Figure 6.3).  
Figure 6.3  Optimal condition for perfect discrimination between substrate and 
product. Relative fluorescence intensity of dye conjugated peptides in various 
combination of solvent. The maximum intensities were measured at ex 390 / em 
450 nm except for 0.1% TFA and TFA/ACN. In case of TFA containing solvent, 
the maximum signal was measured at ex 360 /em 450 nm (F0 : fluorescence of 
















Upon mixing reaction mixture containing 20 pmol of each peptide with 0.5 
µg of TiO2-GO in 0.1 % TFA / 50% ACN, phosphorylate peptides immediately 
showed remarkable fluorescence decrease, whereas the substrate peptide 
maintained the strong fluorescence signal (Figure 6.4a,b).  
We then performed time-dependent and kinase concentration dependent 
phosphorylation using PKA and peptide 1. Reaction mixtures were prepared by 
adding various concentration of PKA to substrate peptide solution containing 20 
pmol of peptide and 200 pmol of ATP as phosphate group donor. Then, 2 μL of 
the PKA reaction mixture was removed at 10 min intervals and mixed 
immediately with 100 μL of 5 μg/mL TiO2-GO in 0.1 % TFA/50% ACN in a 96-
well plate. The fluorescence intensity was collected for each well using a 
fluorometer. As a result, the fluorescence signal was decreased according to 
reaction time and PKA concentration. It indicated that the phosphorylation ratio 
was increased depending on reaction time and enzyme concentration (Figure 
6.4c,d).  
Next, we carried out inhibition assays using two kinases and each 
corresponding inhibitors to confirm that the present method was quantitative and 
applicable to the evaluation of inhibitors. H-8919 and 5-iodotubercidin20 were well 
known as PKA and ERK2 inhibitors, respectively. For PKA inhibition, various 
concentrations of H-89 were incubated with PKA reaction mixture containing 20 




were obtained after mixing reaction mixtures with TiO2-GO in TFA/ACN. Dose-
dependent inhibition curves were plotted based on fluorescence intensities and the 
IC50 value was estimated to be 1.5 μM (Figure 6.4e). Similarly, 1 uM ERK2 with 
5-iodotubercidin also showed dose-dependent inhibition curve and 0.94 μM as 







Figure 6.4  Protein kinase activity assay using TiO2-GO. Selective fluorescence 
quenching of corresponding dye conjugated to phosphorylated peptide by a) PKA 
and b) ERK2. c) Time-dependent and d) kinase concentration dependent 
fluorescence analysis for phosphorylation of substrate peptide by PKA. e) PKA 
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To investigate capability of multiplexed kinase assay in a mixed solution, we 
conducted phosphorylation reaction of peptide 1 and 2 in the presence of both 
PKA and ERK2 in a solution, followed by mixing with TiO2-GO in TFA/ACN. 
We first optimized TiO2-GO concentration for multi-peptide analysis using 
phosphorylated or nonphosphorylated peptides mixture. 15 μg/mL TiO2-GO was 
required for quenching of both phosphorylated peptides, and additional 0.0025% 
BSA was utilized to recover the selectivity under the high concentration of TiO2-
GO (Figure 6.5).  
Figure 6.5  Enhancement of discrimination between substrate and product in 
multiplex assay. Relative fluorescence intensity of a) Coumarin-PKA substrate 
and b) TAMRA-ERK2 substrate with various concentration of TiO2-GO  and/or 
BSA in TFA/ACN. BSA was a great help to prevent adsorption of substrate 
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On the basis of the results, kinase specific phosphorylation was examined by 
mixing each kinase or combination of kinases with peptide solution containing 
substrate 1 and peptide 2 and ATP. The reaction mixtures were added to newly 
optimized TiO2-GO in TFA/ACN, followed by measuring the fluorescence signal. 
As expected, each emission of coumarin (blue, ex 360 / em 450 nm) and TAMRA 
(yellow, ex 550 / em 585nm) were decreased only in the sample containing each 
corresponding target kinase (Figure 6.6a). Furthermore, we carried out each 
inhibitor specific nonphosphorylation test using H-89 and 5-iodotubercidin, as 
PKA inhibition and ERK2 inhibitor, respectively (Figure 6.6b). Reaction mixture 
was prepared by pre-incubation of inhibitors with kinases, followed by adding to 
peptides solution containing peptide1, peptide2 and ATP. After incubation for 1hr, 
the reaction mixtures were added to TiO2-GO in TFA/ACN, followed by 
measuring the fluorescence intensity. As a result, blue and yellow emission were 
obtained only in the sample containing each corresponding inhibitor. These 
results are in good accordance with MS based analysis of peptides (Figure 6.6c,d). 
It appears that the present protein kinase activity assay platform can be applicable 






Figure 6.6  Multiplex inhibition assay of PKA and ERK2 in a homogeneous 
solution using TiO2-GO based fluorescence analysis. a) Peptide sequence specific 
phosphorylation: Relative fluorescence intensity (FSubstrate = 1) of two kinase 
substrate mixture with kinases. b) Inhibitor specific unphosphorylation : Relative 
fluorescence intensity (FSubstrate = 1) kinase reaction mixtures with each specific 
inhibitor. Inhibitor 1 : H-89/ PKA inhibitor,  Inhibitor 2 : 5-
iodotubercidin/ERK2 inhibitor. MALDI-TOF mass spectra of two kinds of 
peptides in a solution for c) phosphorylation with corresponding protein kinase, 
d) inhibition of phosphorylation by specific inhibitors in the presence of both 
PKA and ERK2. 
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M1 : hydroxycoumarin-PKA substrate
M2 : phosphorylated 7-coumarin-PKA substrate
M3 : TAMRA-ERK2 substrate
M4 : phosphorylated TAMRA-ERK2 substrate



























Finally, to demonstrate the practical utility of this platform, we performed 
multiplexed, high-throughput screen for protein kinase inhibitors. Before the full 
scale study of screening of protein kinase inhibitor using the present platform, 
simple statistic parameter called “Z’-factor” was calculated to access the quality 
of the screening assay (Figure 6.7).21 Generally, when Z’ factor reaches 0.75 or 
higher, the corresponding system can be judged to be high performance assay.22 
To obtain the Z’-factor, we analyzed 20 positive and 20 negative control reactions 
using the present platform, followed by calculation of the each mean (σ) and each 
standard deviation (STD, µ). The Z’-factor obtained by using the equation (Z’ 
factor = 1 – (3σc++3σc-) / |µc+–µc-|) was 0.90 for PKA and 0.84 for ERK2, 















Figure 6.7  The Z’-factor was calculated for TiO2-GO based platform from each 




Then, we screened a library of structurally diverse and medicinally active 
707 compounds for discovery of protein kinase inhibitor. Each bioactive 
compound was mixed with protein kinase cocktail composed of PKA and ERK2 
in 96 well plates. After that, peptides and ATP solution were added to the mixture 
for beginning the kinase reaction. Positive and negative control reactions was run 
with every 88 compound screening. After 1hr of reactions, the mixtures was 
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added to TiO2-GO in TFA/ACN, which induced the fluorescence quenching of 
dye of phosphorylated peptides without kinase inhibition, selectively. 
Among the compounds of the library, 2 compounds (PIK-75 Hydrochloride, 
AT7867) showed strong blue emission over 50% of negative control and other 2 
compounds (PHA-793887, Fisetin) showed strong yellow emission over 50% of 
negative control (Figure 6.8a, for the clear contrast of color, yellow emission was 
visualized as red in the 1st screening). The inhibition of phosphorylation by the 4 
selected compounds was quantitatively analyzed by secondary inhibition assay 
(n=3) (Figure 6.8b), and the inhibition was confirmed by measuring molecular 
weight of peptides in reaction mixtures using MS based system (Figure 6.8c). 
Through the screening of compound library using the present platform, we 
identified PIK-75 Hydrochloride and PHA-793887, widely known inhibitors of 
PI3 kinase23 and cyclin-dependent kinase,24 as a potent PKA and ERK2 inhibitor, 
respectively. Also, the corresponding kinase inhibition by AT786725 and fisetin26 





Figure 6.8  Multiplex protein kinase (PKA and ERK2) inhibitor screening using 
a set of bio-active molecules. a) At first, 703 compounds were screened for PKA 
and ERK2 in a homogeneous solution using TiO2-GO based fluorescence analysis. 
b) Next, the selected molecules (relative fluorescence intensity > 0.5) were 
screened again using TiO2-GO based fluorescence analysis and MALDI-TOF 
based analysis. d) MALDI-TOF mass spectra for inhibition of phosphorylation of 
each peptides by selected compounds from multiplexed screening assay. 
 
 
We further characterized the discovered inhibitors by using the present 
platform to evaluate their quantitative inhibitory effect toward the respective 
protein kinase. PKA with PIK-75 hydrochloride or AT7867 showed dose 
dependent inhibition curve and 4.5 μM and 2.3 μM as IC50 value, respectively 




dependent inhibition curve and 10 μM and 8.9 μM as IC50 value, respectively 
(Figure 6.9c,d). Consequently, we could screen a set of bioactive small molecules 
using multiplex assay method and successfully discover the specific inhibitors of 
each kinase.  
 
Figure 6.9  Protein kinase inhibition assay using 4 compounds discovered from 
three screens. PKA inhibition curve and IC50 using a) PIK-75 hydrochloride and 
b) AT7867. ERK2 inhibition curve and IC50 using c) PHA-793887 and d) Fisetin. 
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6.3  Conclusion 
In conclusion, we developed a robust and quantitative protein kinase activity 
assay platform using TiO2-GO hybrid nanomaterial and applied to screen the 
hundreds of small molecules for target specific inhibitor discovery. The analysis 
of protein kinase activity was performed by two steps, 1) protein kinase reaction 
with dye labelled substrate peptide in a reaction buffer, 2) selective fluorescence 
quenching of phosphorylated peptide by TiO2-GO in TFA/ACN. Each TiO2 and 
GO plays important roles, adsorbing phosphorylated peptide and quenching the 
fluorescence of dye conjugated to peptide, respectively. The sequential event can 
occur in a few seconds that allows robust and time-efficient analysis of protein 
kinase activity. In addition, the hybrid nanomaterial makes the present method 
more inexpensive because unlike typical assays, expensive reagents such as 
isotopes and fluorescent antibodies are not required. Furthermore, the 
combination of acidic condition (TFA), organic solvent (ACN) and BSA showed 
a synergetic effect for preventing the nonspecific adsorption of non-
phosphorylated peptide on TiO2-GO, resulting in high sensitivity and selectivity. 
This method is technically straightforward and compatible with multiplexd assay 
formats. The utility of the present platform has been demonstrated by discovering 
the inhibitors through multiplexed inhibitor screening for two protein kinase 
using hundreds of bioactive compounds. Finally, this platform, based on TiO2-GO, 




sequence of peptide substrate because the selective fluorescence quenching only 
depends on an additional phosphate group transferred by protein kinase. We 
believe that this new TiO2-GO based fluorescent platform for protein kinase 
activity assay will become an important assay tool in the field of protein kinase 




















6.4  Material and Methods 
Materials.   Sulfuric acid (H2SO4) was purchased from Samchun chemical 
(Seoul, Korea). Titanium(IV) butoxide (Ti(BuO)4) was purchased from Sigma-
Aldrich (MO, USA). 7-Hydroxycoumarin-3-carboxylic acid was purchased from 
Anaspec (California, USA). 5-(and-6)-Carboxytetramethylrhodamine was 
purchased from Invitrogen (Massachusetts, USA). 
 
Preparation of TiO2 decorated GO.    3ml of 1 mg/ml of GO was dissolved in 
150 ml EtOH and the suspension was heated to 80 °C with stirring. 28 μL of 
Ti(BuO)4 and 16 μL of H2SO4 was prepared in 4 mL of EtOH, which was injected 
in the mixture. The final solution was stirred at 80 °C for 12 h. Then, the reaction 
mixture was cooled down and the TiO2-GO was collected by centrifugation, 
followed by washing with EtOH and water.  
 
Protein kinase A assay using TiO2-GO.   For phosphorylation by kinase, 20 
pmol of dye conjugated substrate peptide and 200 pmol of ATP was mixed with 
corresponding kinase in Tris-HCl buffer (pH 7.4 buffer containing 40 mM Tris 
and 20 mM MgCl2). After incubation at 30 ℃, 0.5 μg of TiO2-GO pre-dispersed 
in 50% ACN and 0.1% TFA was added to the reaction mixture. Fluorescence 





Multiplex Protein kinase inhibition assay.    For multiplex inhibition assay 
using H-89 and 5-iodotubercidin, each 40 μM of inhibitors was prepared in 
kinase mixture containing 20 U/ml of PKA and 1 μM of ERK2. Then, each 20 
pmol of coumarin-PKA substrate and TAMRA-ERK2 substrate was mixed with 
400 pmol of ATP in Tris-HCl buffer (pH 7.4 buffer containing 40 mM Tris and 20 
mM MgCl2), which was added to kinase/inhibitor mixture. After incubation at 
30 ℃, for 1 hr, 1.5 μg of TiO2-GO pre-dispersed in 50% ACN and 0.1% TFA was 
added to the reaction mixture. Fluorescence intensity was measured at 
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In summary, we have demonstrated five different fluorescent sensing systems 
based on GO for quantitative analysis of biomolecules that were considered as 
important biological targets in the field of clinical diagnosis and drug discovery. 
These platforms commonly utilized GO as a super-quencher that was capable of 
fluorescence quenching across the entire visible spectrum and they were 
classified into two categories according to each purpose : 1) nucleic acid 
detection, 2) enzyme activity assay.  
First, the nucleic acid detection systems employed artificial PNA probe 
instead of typical DNA probe in GO based sensor for improved performance, 
which were impossible to achieve by using conventional DNA probe. 
Combination of PNA probe and GO enabled double stranded DNA detection 
without denaturing step and highly effective single mismatch discrimination. Also, 
by applying BSA in the PNA/GO based system, the detection sensitivity was 
remarkably improved. Secondly, the enzymatic assay platforms were designed on 
the basis of the selective fluorescence quenching of dye conjugated to product by 
GO in a short time and aimed at high throughput fluorometric analysis of target 
enzymes. These assay platforms aren’t restricted by sequence or overall charge of 





These GO based sensor systems are cost/time-effective and technically 
straightforward. These sensors were designed based on understanding at a 
molecular level how it works, resulting in noticeable improvement of the sensing 
performance compared to conventional systems. We believe that the present 
platforms will become an important assay tool in the field of personalized 



















Summary in Korean (국문요약)  
산화그래핀을 이용한 형광 기반 생분자 분석 플랫폼의 개발  
   단백질이나 핵산, 지질 등 인체 내 존재하는 생분자들 중 일부는 외부 
환경으로부터의 자극 또는 체내 변화에 민감하게 변화하며 이러한 특정 생분자 
(생체지표)를 분석하는 것은 특정 질병의 진단뿐만 아니라 치료를 목적으로 하는 
신약 개발 분야에서 중요하게 사용되는 수단 중 하나이다. 일반적으로 전기영동, 
면역분석법, 항체기반 분석법 등을 이용하여 생분자를 분석하는 방법이 
사용되어왔으나 이러한 시스템들은 최근 요구되는 목적에 부합하는 높은 레벨의 
분석 사양보다 비교적 낮은 민감도와 정확도를 보이는 경우가 많다. 또한 노동 
집약적인 실행이 요구되며, 비효율적인 시간 및 비용의 소모가 있어 대량의 샘플에 
대한 분석에 적합하지 않다. 최근 다양한 접근을 통해 기존의 시스템을 대체하면서 
보다 높은 성능을 갖는 시스템 개발하기 위한 연구가 진행되고 있으며 특히 그 중 
금, 실리카, 탄소등으로 이루어진 나노 크기의 입자를 이용한 시스템의 개발이 
활발하게 진행되고 있다. 이러한 나노입자들은 작은 사이즈에 비하여 큰 표면적을 
가지고 있으며 이로 인해 같은 원소로 이루어진 큰 사이즈의 물질과는 다른 고유의 
특성을 지니게 되므로 이를 이용하여 형광, 전기화학, 분자량분석 또는 
표면라만증강에 기반한 다양한 바이오센서 개발이 가능하다. 이들은 기존 분석 
시스템에 비하여 간단하고 빠른 검출이 가능하며 보다 높은 검출 성능을 보여주고 
있다.  
   본 연구에서는 생체지표가 되는 다양한 생분자의 정량적 분석을 위하여 




탄소구조체인 그래핀에 산화과정을 통해 친수성 작용기를 도입시킨 유도체로 그래핀 
자체의 물리적, 광학적 고유특성을 일정 수준으로 유지함과 동시에 수용액에서 잘 
분산되기 때문에 나노-바이오분야에서 주목을 받고 있는 나노물질 중 하나이다. 본 
연구에서 개발된 플랫폼들은 산화그래핀의 다양한 특성 중 약 20 nm 내에 존재하는 
형광염료의 형광신호를 소광시키는 성질에 기반하였으며 형광염료가 부착된 프로브 
혹은 효소의 기질을 이용하여 디자인되었다. 이들은 목적에 따라 감염 및 질병의 
진단 타겟이 될 수 있는 이중나선 DNA, 단일가닥 DNA 또는 RNA, 유전자의 개체간 
단일염기변이의 검출을 위한 핵산분석 시스템과 신약개발의 타겟이 되는 DNA 
엑소뉴클레아제와 단백질 키나아제의 분석을 위한 효소활성분석 시스템으로 크게 
나누어 볼 수 있다. 공통적으로 기존 분석 시스템들이 가지고 있는 단점을 극복함과 
동시에 정량적인 실시간 검출 및 고속대량분석을 목표로 진행되었으며 테스트 
과정을 통하여 높은 검출 효율과 다양한 응용가능성을 확인하였다. 이 시스템들은 
이후 개인 질병의 진단, 신약개발뿐만 아니라 각각의 생분자에 관한 기초 연구에 
중요한 수단이 될 수 있을 것으로 기대된다. 
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